Sign In
close X
The user name and password you entered does not match
the information we have on file.
Forgot your password?
Contact us
close X
Please enter a valid code.
Contact us
Home
|
Texts
|
Drugs
|
Images
|
Guidelines
|
Patient Education
Showing Results for
study of tamoxifen and raloxifene
Narrow Results
Topics
All Topics (6)
adverse events (1)
quality of life (1)
Content Types
All (6)
Texts (6)
NCI Clinical Trials
Looking for trials?
Go to NCI and browse 8,000+ trials
6
Search Results
Principles and Practice of Gynecologic Oncology
Chapter 29. Breast Cancer >
NSABP P-2 (STAR Trial): Study of Tamoxifen and Raloxifine
This was a prospective randomized double-blind trial comparing raloxifine 60 mg/day to tamoxifen 20 mg/day as primary prevention of invasive breast cancer (166). Eligible patients were 35 and over and ...
Diseases of the Breast
Chapter 22. Chemoprevention: Clinical Aspects >
The Star Trial
Data from the osteoporosis trials, along with substantial laboratory evidence, indicated that raloxifene could reduce the incidence of primary breast cancer (10). To compare the relative effects and safety of ...
Diseases of the Breast
Chapter 22. Chemoprevention: Clinical Aspects >
Quality of Life in the STAR Trial
In the STAR trial, patient-reported symptoms were collected from all participants using a 36-item symptom checklist such as that used in the NSABP Breast Cancer Prevention Trial (22). Quality of ...
Diseases of the Breast
Chapter 22. Chemoprevention: Clinical Aspects >
Adverse Events in the STAR Trial
In the STAR trial, there were 36 cases of uterine cancer with tamoxifen and 23 with raloxifene, a difference that approached statistical significance. No differences were found for other invasive ...
Principles and Practice of Gynecologic Oncology
Chapter 17. Hormones and Human Malignancies > SERMs
The STAR trial (Study of Tamoxifen and Raloxifene), powered to ...
Diseases of the Breast
Chapter 25. Lobular Carcinoma In Situ: Clinical Management > Chemoprevention
The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial ...
Didn't find what you were looking for?
Run a full-text search on 'study of tamoxifen and raloxifene'
What do you think of LWWOncology?
Share Your Feedback
More Results
Journal Results from PubMed
Exemestane for breast-cancer prevention in postmenopausal women.
N. Engl. J. Med. | Jun 23, 2011
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
J. Clin. Oncol. | Jun 9, 2011
Effect of changing breast cancer incidence rates on the calibration of the Gail model.
J. Clin. Oncol. | May 7, 2010
Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.
J. Clin. Oncol. | Oct 30, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
J. Clin. Oncol. | Jun 30, 2009
View More on PubMed
>